Physician profile
Alysha Naran
NPI 1043033251
$1,553.20
in general payments reported to CMS, 2019-2025
17 companies · $1,553 in 2025
The $1,553 reported for 2025 was more than what 94% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,553.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $430.48 | 2025 | Urolift, Barrigel |
| Coloplast Corp | $430.06 | 2025 | |
| Sumitomo Pharma America, INC. | $162.35 | 2025 | Orgovyx, Gemtesa |
| Sun Pharmaceutical Industries INC. | $122.46 | 2025 | |
| Antares Pharma, INC. | $49.92 | 2025 | Xyosted |
| Convatec INC. | $49.22 | 2025 | |
| Pfizer INC. | $42.33 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $35.04 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Ferring Pharmaceuticals INC. | $34.30 | 2025 | Adstiladrin |
| Janssen Biotech, INC. | $34.06 | 2025 | Erleada |
| Merck Sharp & Dohme LLC | $32.83 | 2025 | Keytruda, Welireg |
| Medtronic, INC. | $29.44 | 2025 | Interstim |
| Tempus Ai, INC | $28.58 | 2025 | Xt Cdx |
| Avyxa Pharma, LLC | $23.00 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.22 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cycle Pharmaceuticals INC | $17.10 | 2025 | Venxxiva |
| Laborie Medical Technologies Corp. | $11.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alysha Naran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.